|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.68 SEK | -2.91% |
|
+15.09% | +62.56% |
| Apr. 18 | Diamyd Medical Raises SEK57 Million in Rights Issue | MT |
| Apr. 12 | Recruitment Milestone Reaches in Diamyd® Phase 3 Trial | CI |
Diamyd Medical AB (publ) reported earnings results for the fourth quarter ended August 31, 2022. For the fourth quarter, the company reported sales was SEK 0.059 million compared to SEK 0.051 million a year ago. Revenue was SEK 1.16 million compared to SEK 0.167 million a year ago.
Net loss was SEK 36.73 million compared to SEK 27.37 million a year ago. Basic loss per share from continuing operations was SEK 0.5 compared to SEK 0.4 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +62.56% | 103M | |
| -3.46% | 102B | |
| +1.41% | 96.29B | |
| +2.13% | 22.18B | |
| -15.84% | 21.2B | |
| -9.21% | 18.31B | |
| -39.98% | 17.38B | |
| -14.65% | 16.36B | |
| +4.39% | 13.97B | |
| +31.35% | 12.17B |
DIAMYD MEDICAL AB 
